Filter
Showing 1–15 of 44 results
Participants will be able to design structured technology transfer plans, identify critical process parameters and quality attributes, apply risk assessment tools, manage documentation requirements, and ensure smooth transfer execution aligned with regulatory expectations.
Participants will be able to design compliant primary and secondary packaging systems, assess material compatibility, integrate serialization requirements, apply risk-based packaging validation, and implement sustainable packaging strategies aligned with global regulatory expectations.
Participants will be able to develop validation master plans, apply risk-based validation approaches, execute process and equipment qualification, manage documentation, and ensure inspection readiness aligned with global regulatory standards.
Participants will gain the ability to apply executive coaching using the GROW model, improve performance management, strengthen leadership development, enhance field effectiveness, and drive results through structured coaching.
Participants will develop the ability to understand the unique dynamics of pharmaceutical selling, manage territories effectively, and conduct impactful doctor interactions within limited consultation time. They will learn how to plan productive field calls, build professional relationships with healthcare professionals, support prescription generation, collaborate with chemists to ensure prescription fulfillment, and maintain professional conduct and compliance standards in pharmaceutical marketing.
Participants will develop the ability to lead and manage medical representative teams, analyze field reports and market intelligence, and drive territory-level business performance. They will learn how to coach team members through joint field work, support consultative selling, onboard new representatives effectively, manage vacant territories without business disruption, and use RCPA insights to guide strategy execution and improve market competitiveness.
Participants will develop the ability to evaluate pharmaceutical capital investments using financial modeling, clinical development insights, and regulatory risk assessment. They will learn how to assess project feasibility, estimate long-term value, and prioritize investment opportunities that support innovation, regulatory compliance, and sustainable business growth.
Participants will learn how pharmaceutical products are costed and priced across global markets while considering regulatory controls, reimbursement frameworks, and competitive dynamics. They will develop the ability to evaluate drug development costs, design value-based pricing models, and create international pricing strategies aligned with market access objectives and profitability goals.
Participants will gain a clear understanding of the stages involved in pharmaceutical drug discovery and development. They will learn how drug targets are identified, how potential drug candidates are screened and optimized, and how preclinical and clinical studies are designed to evaluate safety and efficacy. The program will also develop understanding of regulatory approval pathways, commercialization considerations, and emerging technologies that are transforming pharmaceutical research and development.
Participants will gain the ability to design risk-based audit programs, conduct internal and supplier audits, evaluate findings, and implement effective CAPA systems to strengthen quality compliance.
Participants will gain the ability to prepare for regulatory inspections, evaluate compliance gaps, manage audit interactions, and develop corrective and preventive actions following regulatory observations.
Participants will gain the ability to analyze pharmaceutical cost structures, design strategic pricing models for different markets, and balance profitability with regulatory and market access requirements.
Participants will gain the ability to assess audit readiness, identify compliance gaps, manage inspection processes, conduct internal audits, and implement corrective and preventive actions to sustain regulatory compliance.
Participants will gain the ability to analyze global pharma trends, evaluate business and operating models, assess market opportunities, and develop strategies to drive growth and competitive advantage.
Participants will gain the ability to evaluate non-US pharmaceutical markets, understand regional regulatory pathways, design market entry strategies, and build partnerships that support sustainable international growth for Indian pharmaceutical companies.